Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Schemes in Hospitalized T2DM
NCT03350984Phase 4Completed
- Sponsor
- Universidad de Guanajuato
- Start
- Nov 2017
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin isophane in type 2 diabetes mellitus (T2DM), sponsored by Universidad de Guanajuato. Started Nov 2017; status: completed.
02
Drugs
insulin isophane
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03350984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350984.